April 12 (Reuters) - Telesta Therapeutics Inc TST.TO
* Says type a meeting has been scheduled with u.s. Food and
drug administration (fda) on friday, april 15 , 2016
* Type a meeting will be focused on fda's responses to
telesta's questions concerning approval of mcna 1 in united
states
Source text for Eikon: ID:nCNW75q9ha
Further company coverage: TST.TO
(Bengaluru Newsroom: +1-646-223-8780)